The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients
NCT ID: NCT03840499
Last Updated: 2019-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2018-10-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure
NCT03902028
Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure
NCT00311194
the "Level of Resilience" Influencing Self-care in Heart Failure Patients
NCT06146803
Interval Training in Heart Failure
NCT03955029
Monitoring Community Trends in Heart Failure
NCT00035724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Willing to participate in clinical study
Optimal medical therapy
Optimal medical therapy
Not-willing to participate in clinical study
Optimal medical therapy
Optimal medical therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optimal medical therapy
Optimal medical therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singed informed consent
Exclusion Criteria
* Haemodinamically instable, shock, intubation
* Pregnancy, breast feeding
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semmelweis University Heart and Vascular Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semmelweis University, Heart and Vascular Center
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Study survival - v. 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.